Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Case Reports

Full-thickness Macular Hole after Intravitreal Aflibercept Injection in a Patient with Wet Age-related Macular Degeneration.: Gwonhwee Lee, Seungwoo Lee; J Korean Ophthalmol Soc. 2017;58(7):875-878. Published online July 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.7.875
Crossref 3; PDF

Original Articles

Comparison of Choroidal Thickness Change between Ranibizumab and Aflibercept in Age-related Macular Degeneration: Six Month Results.: Im Gyu Kim, Yong Il Kim, Jin Seon Kim, Jung Ho Lee, Kyoo Won Lee, Hyun Gu Kang; J Korean Ophthalmol Soc. 2017;58(3):296-304. Published online March 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.3.296
Crossref 6; PDF

Efficacy of Three Aflibercept Injections for Neovascular Age-related Macular Degeneration Showing Limited Response to Ranibizumab.: Kyung Min Kim, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee; J Korean Ophthalmol Soc. 2017;58(1):62-68. Published online January 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.1.62
Crossref 4; PDF

Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients.: Ji Sang Min, Hyun Chul Jung, Ji Young Suh, Yoon Hyung Kwon; J Korean Ophthalmol Soc. 2016;57(11):1738-1744. Published online November 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.11.1738
Crossref 6; PDF

Comparison of Optical Coherence Tomography Characteristics among Three Subtypes of Exudative Age-related Macular Degeneration.: Soh Eun Ahn, Dong Seob Ahn, Heon Yang, Hee Seong Yoon; J Korean Ophthalmol Soc. 2016;57(7):1093-1101. Published online July 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.7.1093; PDF

Intravitreal Anti-Vascular Endothelial Growth Factor for Retinal Pigment Epithelial Tear in Retinal Angiomatous Proliferation.: Hyun Ji Hwang, Young Suk Chang, Jong Woo Kim et al.; J Korean Ophthalmol Soc. 2016;57(1):71-79. Published online January 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.1.71
Crossref 2; PDF

Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Resistant to Bevacizumab and Ranibizumab.: Jong Ha Kim, Nam Chun Cho, Woo Jin Kim; J Korean Ophthalmol Soc. 2015;56(9):1359-1364. Published online September 15, 2015; DOI: https://doi.org/10.3341/jkos.2015.56.9.1359
Crossref 13; PDF

Use of Fundus Autofluorescence Images to Evaluate the Progression of Geographic Atrophy: Two-Year Follow-Up Study.: Won Tae Yoon, Sung Pyo Park; J Korean Ophthalmol Soc. 2015;56(8):1195-1200. Published online August 15, 2015; DOI: https://doi.org/10.3341/jkos.2015.56.8.1195; PDF

Correlation between Visual Outcomes and Pre-Treatment Factors Including Hyperreflective Foci in Neovascular Age-Related Macular Degeneration.: Hyung Woo Lee, Hyung Chan Kim; J Korean Ophthalmol Soc. 2015;56(8):1188-1194. Published online August 15, 2015; DOI: https://doi.org/10.3341/jkos.2015.56.8.1188
Crossref 4; PDF

Comparison of Retinal Nerve Fiber Layers in Patients with Non-Neovascular Age-Related Macular Degeneration and Normal Controls.: Jae Young Kim, Hyewon Chung, Hyung Chan Kim; J Korean Ophthalmol Soc. 2014;55(9):1334-1339. Published online September 15, 2014; DOI: https://doi.org/10.3341/jkos.2014.55.9.1334; PDF

Bevacizumab Monotherapy Versus Combined Therapy with Photodynamic Therapy for Occult Choroidal Neovascularization in Age-Related Macular Degeneration.: Jong Hyun Oh, Seong Woo Kim, Jaeryung Oh, Soon Sun Kwon, Kuhl Huh; J Korean Ophthalmol Soc. 2013;54(10):1554-1560. Published online October 15, 2013; DOI: https://doi.org/10.3341/jkos.2013.54.10.1554; PDF

Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated for Age-Related Macular Degeneration.: Jung Jin Lee, Young Ju Lew, Sung Won Cho, Jong Woo Kim; J Korean Ophthalmol Soc. 2013;54(10):1534-1539. Published online October 15, 2013; DOI: https://doi.org/10.3341/jkos.2013.54.10.1534
Crossref 5; PDF

Long-Term Effect of Intravitreal Ranibizumab Injection on Choroidal Neovascularization in Age-Related Macular Degeneration.: Hyo Ju Jang, Su Jeong Song, Jeong Hoon Bae; J Korean Ophthalmol Soc. 2013;54(9):1359-1364. Published online September 15, 2013; DOI: https://doi.org/10.3341/jkos.2013.54.9.1359
Crossref 9; PDF

The Efficacy of Vaccinium Uliginosum for Early Age-Related Macula Degeneration.: Hyun Kyung Kil, You Mi Song, Koi Chun; J Korean Ophthalmol Soc. 2013;54(8):1255-1260. Published online August 15, 2013; DOI: https://doi.org/10.3341/jkos.2013.54.8.1255
Crossref 5; PDF

Combined Anti-VEGF and C3F8 Injection for Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration.: Min Young Lee, Won Moon Seo, Yul Je Choi; J Korean Ophthalmol Soc. 2013;54(3):443-448. Published online March 15, 2013; DOI: https://doi.org/10.3341/jkos.2013.54.3.443
Crossref 5; PDF

Volume 67, No. 5

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

6,505	Self-assessment of Visual Acuity Using a Smartphone Application
4,602	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
3,075	Central Anticholinergic Syndrome Induced by Atropine Eye Drops: A Case Report
1,768	Efficacy of 1% Ivermectin Ointment for Demodex Blepharitis
3,253	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Cited By 4	The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery
Cited By 3	A Case of Retinal Vasculitis, Uveitis in Myelin Oligodendrocyte Glycoprotein Antibody Associated Optic Neuritis
Cited By 2	What Laboratory Examinations for Open-angle Glaucoma Risk Stratification
Cited By 2	Comparison of Clinical Outcomes Among Sutured, Sutureless Scleral Fixation, and Retropupillary Fixation of Intraocular Lens
Cited By 2	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2026 by Korean Ophthalmological Society.

prev

next